We serve Chemical Name:2,6-dichloro-4-(trifluoromethylsulfanyl)phenol CAS:102794-04-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,6-dichloro-4-(trifluoromethylsulfanyl)phenol
CAS.NO:102794-04-7
Synonyms:Phenol,2,6-dichloro-4-[(trifluoromethyl)thio];2,6-dichloro-4-(trifluoromethylthio)phenol;2,5-DIBROMO-3,6-DIFLUOROBENZENESULFONYL CHLORIDE
Molecular Formula:C7H3Cl2F3OS
Molecular Weight:263.06400
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:198.9ºC at 760 mmHg
Density:1.68 g/cm3
Index of Refraction:1.566
PSA:45.53000
Exact Mass:261.92300
LogP:4.31090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Phenol,2,6-dichloro-4-[(trifluoromethyl)thio] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,5-DIBROMO-3,6-DIFLUOROBENZENESULFONYL CHLORIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-dichloro-4-(trifluoromethylthio)phenol Use and application,2,5-DIBROMO-3,6-DIFLUOROBENZENESULFONYL CHLORIDE technical grade,usp/ep/jp grade.
Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 2,6-dichloro-4-(trifluoromethylsulfanyl)phenol manufacturer The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 2,6-dichloro-4-(trifluoromethylsulfanyl)phenol supplier During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. 2,6-dichloro-4-(trifluoromethylsulfanyl)phenol vendor Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 2,6-dichloro-4-(trifluoromethylsulfanyl)phenol factory During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology.
